HopeStage
Back to all studies
WithdrawnNCT02398318

China Refractory OCD Deep Brain Stimulation Study

Device studyAges 18–60China
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 60 years.

Listed locations
Guangzhou and 2 more locationsSee all locations and recruitment
Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateApril 2015
Recruitment status
Withdrawn
Enrollment listed in the registry
0
Sponsor
Ruijin Hospital
Sponsor type
Hospital / academic medical center
Study type
Device
Intervention type
Device
Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
China
Age range
From 18 Years to 60 Years
Official registry ID
NCT02398318
Official title
Show the full official title

China Refractory-Obsessive Compulsive Disorder Deep Brain Stimulation Study

Recruitment & locations

Withdrawn

Guangzhou · Shanghai · Chengdu

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Ruijin Hospital, a hospital or academic medical center.

Who can participate?

Listed age limits: 18 years to 60 years.

Is this study still recruiting?

The registry lists this study as withdrawn.

Want to explore more studies?

Explore studies